International audienceMetal ions such as zinc and copper can have dramatic effects on the aggregation kinetics of and the structures formed by several amyloidogenic peptides/proteins. Depending on the identity of the amyloidogenic peptide/protein and the conditions, Zn(II) and Cu(II) can promote or inhibit fibril formation, and in some cases these metal ions have opposite effects. To better understand this modulation of peptide aggregation by metal ions, the impact of Zn(II) binding to three amyloidogenic peptides (Aβ14-23, Aβ11-23, and Aβ11-28) on the formation and structure of amyloid-type fibrils was investigated. Zn(II) was able to accelerate fibril formation for all three peptides as measured by thioflavin T fluorescence and transmissi...
Self-assembly of amyloidogenic peptides and their metal complexes are of multiple interest including...
Many transition metal ions modulate the aggregation of different amyloid peptides. Substoichiometric...
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 million people ...
International audienceMetal ions such as zinc and copper can have dramatic effects on the aggregatio...
Supramolecular assembly of peptides and proteins into amyloid fibrils is of multifold interest, goin...
Aggregation of amyloid-β (Aβ) peptides is a central phenomenon in Alzheimer's disease. Zn(II) and Cu...
The accumulation of senile plaques composed primarily of aggregated amyloid β-peptide (Aβ)...
International audienceSeveral diseases share misfolding of different peptides and proteins as a key ...
Recently discovered evidences suggest that precipitation of Alzheimer's ??-amyloid (A??) peptide and...
Amyloid Beta-Peptide (1-40) is a protein linked to the initial stages of Alzheimer’s and Parkinson’s...
AbstractAssembly of β-amyloid (Aβ) peptide into toxic oligomers is widely believed to initiate Alzhe...
International audienceAmyloid-plaques are a hallmark of Alzheimer’s disease. They consist mainly of ...
X-ray absorption spectroscopy data show different metal binding site structures in beta-amyloid pept...
X-ray absorption spectroscopy data show different metal binding site structures in beta-amyloid pept...
Misfolding of proteins into amyloid structures is implicated as a pathological feature in several ne...
Self-assembly of amyloidogenic peptides and their metal complexes are of multiple interest including...
Many transition metal ions modulate the aggregation of different amyloid peptides. Substoichiometric...
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 million people ...
International audienceMetal ions such as zinc and copper can have dramatic effects on the aggregatio...
Supramolecular assembly of peptides and proteins into amyloid fibrils is of multifold interest, goin...
Aggregation of amyloid-β (Aβ) peptides is a central phenomenon in Alzheimer's disease. Zn(II) and Cu...
The accumulation of senile plaques composed primarily of aggregated amyloid β-peptide (Aβ)...
International audienceSeveral diseases share misfolding of different peptides and proteins as a key ...
Recently discovered evidences suggest that precipitation of Alzheimer's ??-amyloid (A??) peptide and...
Amyloid Beta-Peptide (1-40) is a protein linked to the initial stages of Alzheimer’s and Parkinson’s...
AbstractAssembly of β-amyloid (Aβ) peptide into toxic oligomers is widely believed to initiate Alzhe...
International audienceAmyloid-plaques are a hallmark of Alzheimer’s disease. They consist mainly of ...
X-ray absorption spectroscopy data show different metal binding site structures in beta-amyloid pept...
X-ray absorption spectroscopy data show different metal binding site structures in beta-amyloid pept...
Misfolding of proteins into amyloid structures is implicated as a pathological feature in several ne...
Self-assembly of amyloidogenic peptides and their metal complexes are of multiple interest including...
Many transition metal ions modulate the aggregation of different amyloid peptides. Substoichiometric...
Alzheimer’s Disease (AD) is a progressive, neurodegenerative disease that affects 35 million people ...